This is the authors' abstract. We don't add key points for this paper.
Background and purpose: Because of its antimetabolic and cytotoxic qualities, epirubicin (EP), a crucial chemotherapeutic drug, has been used to treat a number of cancers, including those of the prostate, breast, ovary, stomach, lung, and colon. Experimental approach: /rGO nanocomposite. Key results: /rGO significantly reduced the overpotential of the EP redox reaction and increased the rate of electron transfer between the electrode and analyte as compared to bare SPE. EP was quantitatively analysed using differential pulse voltammetry. Conclusions: /rGO/SPE sensor's practical applicability was investigated in pharmaceutical samples with good recovery outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tajik et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: